| Condition Brief | Condition Text | View |
|---|---|---|
| None | Down Syndrome | View |
| None | Down Syndrome (DS) | View |
| None | Down Syndrome (Trisomy 21) | View |
| None | Alzheimer Dementia | View |
| None | Alzheimer Dementia (AD) | View |
| None | Alzheimer Disease | View |
| None | Alzheimer Disease (AD) | View |
| None | Alzheimer Blood Biomarkers | View |
| None | Epilepsy | View |
| None | Seizures | View |
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Down syndrome | View |
| None | epilepsy | View |
| None | Alzheimer | View |
| None | dementia | View |
| None | levetiracetam | View |
| None | prevention | View |
| None | placebo-controlled | View |
| None | epileptic seizures | View |
| None | Alzheimer's disease markers | View |
| None | phase III | View |
| None | randomized | View |
| None | double-blind | View |
| None | bilateral tonic-clonic seizure | View |
| None | 217-pTau | View |
| None | NfL | View |